Stay updated on Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.

Latest updates to the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated: v3.4.3 replaced by v3.5.0.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was applied and the government funding/operating status notice was removed, with no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a general notice about government funding lapse and NIH Clinical Center operations; updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page now includes a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' field, along with a footer displaying 'No FEAR Act Data' and 'Revision: v3.4.0'. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.